Company Description
Bionovate Techno (OTC Link: BIIO) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $775.0.
BIIO stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of BIIO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bionovate Techno (BIIO) stock last traded at $0.0000. At a market capitalization of $775.0, BIIO is classified as a micro-cap stock with approximately 7.8M shares outstanding.
Latest News
Bionovate Techno has 4 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 0 with negative movement. View all BIIO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Bionovate Techno (BIIO) currently stands at 51 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 51.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Bionovate Techno (BIIO) currently stands at 51.0 days, up 5000% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 5000% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
BIIO Company Profile & Sector Positioning
Bionovate Techno (BIIO) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BIIO often look at related companies in the same sector, including Motus Gi Hldgs Inc (MOTS), Micron Solutions (MICR), Opgen (OPGN), Thermogenesis Holdings Inc (THMO), and Biolase Inc (BIOLQ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BIIO's relative position within its industry.